000			01929 a2200517 4500
005			20250516160807.0
264		0	_c20141112
008			201411s 0 0 eng d
022			_a1996-3181
024	7		_a10.2174/18715273113129990074 _2doi
040			_aNLM _beng _cNLM
100	1		_aDelattre, Ana Marcia
245	0	0	_aMultiple intranigral unilateral LPS infusion protocol generates a persistent cognitive impairment without cumulative dopaminergic impairment. _h[electronic resource]
260			_bCNS & neurological disorders drug targets _cNov 2013
300			_a1002-10 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCognition _xdrug effects
650	0	4	_aCognition Disorders _xchemically induced
650	0	4	_aCorpus Striatum _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopaminergic Neurons _xdrug effects
650	0	4	_aLipopolysaccharides _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMicroinjections
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aParkinson Disease, Secondary _xchemically induced
650	0	4	_aRats
650	0	4	_aRecognition, Psychology _xdrug effects
650	0	4	_aSerotonin _xmetabolism
650	0	4	_aSubstantia Nigra _xdrug effects
700	1		_aCarabelli, Bruno
700	1		_aMori, Marco Aurélio
700	1		_aPudell, Claudia
700	1		_ada Silva, Danielle R B L
700	1		_aMenezes, Isabela
700	1		_aKempe, Paula R G
700	1		_aStaziaki, Pedro Vinícius
700	1		_aDombrowski, Patrícia A
700	1		_ada Cunha, Claudio
700	1		_aLima, Marcelo M S
700	1		_aFerraz, Anete C
773	0		_tCNS & neurological disorders drug targets _gvol. 12 _gno. 7 _gp. 1002-10
856	4	0	_uhttps://doi.org/10.2174/18715273113129990074 _zAvailable from publisher's website
999			_c22908961 _d22908961